Acute thrombosis of the lower limb arteries on the background of the XBB.1.5 ("Kraken") subvariant of omicron SARS-COV-2 - medical or surgical treatment?
Anton Nikolaevich KazantsevAlexander Vladimirovich KorotkikhUnguryan Vladimir MikhailovichBelov Yuri VladimirovichPublished in: Indian journal of thoracic and cardiovascular surgery (2023)
Anticoagulant therapy demonstrates several advantages over aggressive surgical management. However, probably due to the small size of the studied sample, significant differences were not obtained. Further study of this issue is required with the identification of the optimal reperfusion method in this complex cohort of patients.
Keyphrases
- lower limb
- sars cov
- end stage renal disease
- newly diagnosed
- ejection fraction
- healthcare
- atrial fibrillation
- prognostic factors
- liver failure
- acute myocardial infarction
- pulmonary embolism
- peritoneal dialysis
- venous thromboembolism
- heart failure
- respiratory failure
- cerebral ischemia
- respiratory syndrome coronavirus
- intensive care unit
- brain injury
- drug induced
- coronavirus disease
- blood brain barrier
- blood flow
- percutaneous coronary intervention
- patient reported
- bioinformatics analysis